查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602106

吸烟和尼古丁去除产品市场：按产品和分布 - 全球预测 2025-2030

Smoking Cessation & Nicotine De-Addiction Product Market by Product (Drug Therapy, E-Cigarettes, Nicotine Inhalers), Distribution (Drug Store, Hospital Pharmacies, Online Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年戒烟和尼古丁去除产品市值为282.5亿美元，预计到2024年将达到308.9亿美元，复合年增长率为9.65%，到2030年将达到538.7亿美元。

戒烟和尼古丁清除产品市场范围包括尼古丁替代疗法（NRT）、非尼古丁药物、电子烟、尼古丁口香糖、贴片、含片和行为疗法等多种产品。该市场针对寻求戒烟或减少尼古丁成瘾的吸烟者，具有广泛的应用范围，包括个人使用者、医疗机构和復健中心。这些产品的需求是由全球对更健康生活方式的推动、对吸烟相关健康风险的认识的提高以及政府的支持性倡议（例如戒烟和增加烟草製品课税）推动的。影响成长的关键因素包括产品设计的技术进步、戒烟辅助意识的提高以及有利的报销政策。无论是扩大市场影响，利用数位平台接触消费者，还是开发客製化 NRT 和智慧型手机应用程式等创新产品以实现个人化戒烟计划，都存在潜在的机会。然而，市场成长面临严格的法规环境、非专利药竞争加剧以及消费者对戒烟解决方案有效性的怀疑等挑战。对大量临床支援的需求以及满足高安全标准的需求也可能阻碍市场的快速扩张。可以透过策略性地投资于研发以创造更有效且副作用更少的产品，以及形成开发和分销策略联盟来应对限制因素。需要创新的领域包括探索现有 NRT 的替代品、开发个人化医疗方法以及整合技术和科学以提高消费者参与和有效性追踪。竞争考察表明，市场严重倾向于併购活动，以扩大投资组合併开拓未知的人口统计数据，这凸显了保持竞争力的策略调整和敏捷性的必要性。

主要市场统计
基准年[2023] 282.5亿美元
预测年份 [2024] 308.9亿美元
预测年份 [2030] 538.7亿美元
复合年增长率（%） 9.65%

市场动态：快速发展的吸烟和尼古丁去除产品市场的主要市场洞察

供需的动态交互作用正在改变戒烟和尼古丁去除产品市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 吸烟引起的许多疾病的盛行率增加，包括呼吸道疾病和肺癌
    • 全球排毒产品的市场渗透率不断提高
    • 政府积极努力推广无烟政策并意识提升
  • 市场限制因素
    • 由于技术缺陷数量不断增加和核准流程严格，製造商和公司召回产品
  • 市场机会
    • 增加新尼古丁替代产品的核准和开发
    • 线上市场占有率很高，加上社会和地方对戒烟辅助工具的支持
  • 市场挑战
    • 与继续使用戒烟辅助剂和烟草替代品的兴起相关的副作用

波特的五力：驾驭吸烟与尼古丁去除产品市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解外部对戒烟和尼古丁去除产品市场的影响

外部宏观环境因素在塑造戒烟和尼古丁去除产品市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解戒烟和尼古丁去除产品市场的竞争状况

戒烟和尼古丁去除产品市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵戒烟和尼古丁去除产品市场供应商的绩效评估

FPNV定位矩阵是评估戒烟和尼古丁去除产品市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 吸烟引起的各种疾病增加，如呼吸系统疾病和肺癌
      • 扩大成瘾治疗产品的全球市场渗透率
      • 政府采取有利措施促进无烟政策并提高人们对吸烟对健康影响的认识
    • 抑制因素
      • 技术缺陷数量的增加和严格的核准流程导致製造商和公司召回产品
    • 机会
      • 增加新尼古丁替代产品的核准和开发
      • 再加上社会和社区对戒烟产品的支持，它在线上市场上拥有强大的影响力。
    • 任务
      • 与继续使用成瘾治疗药物和烟草替代品增加相关的副作用
  • 市场区隔分析
    • 产品：越来越多采用电子烟来戒烟
    • 分销：由于方便和保密，客户往往更喜欢网上药店
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章吸烟吸烟和尼古丁去除产品市场：副产品

  • 药物治疗
    • Chantix（Varenicline）
    • Zyban（安非他酮）
  • 电子烟
  • 尼古丁吸入器
  • 尼古丁替代疗法
    • 尼古丁口香糖
    • 尼古丁含片
    • 尼古丁喷雾
    • 尼古丁经皮吸收贴片
  • 尼古丁舌下含片

第七章吸烟吸烟和尼古丁去除产品市场经销商

  • 药局
  • 医院药房
  • 网路药房
  • 零售药房

第八章美洲吸烟和尼古丁去除产品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太吸烟和尼古丁去除产品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲吸烟吸烟和尼古丁去除产品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • BC 癌症中心在乔治王子城启动尼古丁替代疗法试验计画
    • 加拿大帝国烟草公司很高兴推出无烟产品
    • NCDHHS 推出了一项新的 QuitlineNC 服务，让戒烟和电子烟变得更容易。

公司名单

  • 22nd Century Group, Inc.
  • Alkalon A/S
  • Axsome Therapeutics, Inc.
  • British American Tobacco PLC
  • Cipla Ltd.
  • Ditch Labs
  • Dr. Reddy's Laboratories Limited
  • Enorama Pharma AB
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Imperial Tobacco Company of India Limited
  • Itaconix
  • Japan Tobacco Inc.
  • Johnson & Johnson
  • JUUL Labs, Inc.
  • Novartis International AG
  • Perrigo Company PLC
  • Pfizer Inc.
  • Philip Morris International Inc.
  • Pierre Fabre SA
  • Rusan Pharma Ltd.
  • Samyang Holdings Corporation
  • Sparsha Pharma International Pvt. Ltd.
  • Strides Pharma Science Limited
Product Code: MRR-03050D1B2D73

The Smoking Cessation & Nicotine De-Addiction Product Market was valued at USD 28.25 billion in 2023, expected to reach USD 30.89 billion in 2024, and is projected to grow at a CAGR of 9.65%, to USD 53.87 billion by 2030.

The scope of the Smoking Cessation & Nicotine De-Addiction Product market includes a diverse range of products such as nicotine replacement therapies (NRT), non-nicotine medications, e-cigarettes, nicotine gums, patches, lozenges, and behavioral therapies. This market targets smokers seeking to quit and reduce nicotine dependency, with applications spanning across individual users, healthcare facilities, and rehabilitation centers. The necessity for these products is driven by the global push toward healthier lifestyles, increasing awareness of smoking-related health hazards, and supportive government initiatives, such as smoking bans and higher taxes on tobacco products. Key influencing growth factors include technological advancements in product design, increasing awareness about smoking cessation aids, and favorable reimbursement policies. Latest potential opportunities lie in expanding market presence in emerging economies, leveraging digital platforms for consumer outreach, and developing innovative products like tailor-made NRTs and smartphone applications for personalized cessation programs. However, market growth faces challenges such as stringent regulatory environments, high competition from generic products, and possible consumer skepticism toward the efficacy of de-addiction solutions. The need for substantial clinical backing and the requirement to meet high safety standards could also hinder swift market expansion. Limiting factors can be countered by strategically investing in R&D to create more effective and less side-effect-prone products and by forming strategic alliances for development and distribution. Areas ripe for innovation include exploring alternatives to currently available NRTs, developing personalized medicine approaches, and integrating technology and science for better consumer engagement and efficacy tracking. Insightfully, the market is evolving with a significant tilt toward merger and acquisition activities, to expand portfolios and tap uncharted demographics, highlighting the need for strategic adaptation and agility to remain competitive.

KEY MARKET STATISTICS
Base Year [2023] USD 28.25 billion
Estimated Year [2024] USD 30.89 billion
Forecast Year [2030] USD 53.87 billion
CAGR (%) 9.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Smoking Cessation & Nicotine De-Addiction Product Market

The Smoking Cessation & Nicotine De-Addiction Product Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing Prevalence of Numerous Diseases due to Smoking Such as Respiratory Disorders and Lung Cancer
    • Expanding Market Penetration of De-Addiction Products Globally
    • Favorable Government Initiatives to Promote Anti-Smoking Policy and Raising Awareness of the Health Impact due to Smoking
  • Market Restraints
    • Product Recalls by the Manufacturer and Companies owing to increasing Technical Faults and Stringent Approval Process
  • Market Opportunities
    • Increasing Approvals and Development of New Nicotine Replacement Products
    • Significant Online Market Presence Coupled with Social and Communal Support for Smoking Cessation Products
  • Market Challenges
    • Side Effects Associated with the Continued Usage of De-Addiction Products Coupled with Rising of Alternatives to Tobacco

Porter's Five Forces: A Strategic Tool for Navigating the Smoking Cessation & Nicotine De-Addiction Product Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Smoking Cessation & Nicotine De-Addiction Product Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Smoking Cessation & Nicotine De-Addiction Product Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Smoking Cessation & Nicotine De-Addiction Product Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Smoking Cessation & Nicotine De-Addiction Product Market

A detailed market share analysis in the Smoking Cessation & Nicotine De-Addiction Product Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Smoking Cessation & Nicotine De-Addiction Product Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Smoking Cessation & Nicotine De-Addiction Product Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Smoking Cessation & Nicotine De-Addiction Product Market, highlighting leading vendors and their innovative profiles. These include 22nd Century Group, Inc., Alkalon A/S, Axsome Therapeutics, Inc., British American Tobacco PLC, Cipla Ltd., Ditch Labs, Dr. Reddy's Laboratories Limited, Enorama Pharma AB, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Imperial Tobacco Company of India Limited, Itaconix, Japan Tobacco Inc., Johnson & Johnson, JUUL Labs, Inc., Novartis International AG, Perrigo Company PLC, Pfizer Inc., Philip Morris International Inc., Pierre Fabre S.A., Rusan Pharma Ltd., Samyang Holdings Corporation, Sparsha Pharma International Pvt. Ltd., and Strides Pharma Science Limited.

Market Segmentation & Coverage

This research report categorizes the Smoking Cessation & Nicotine De-Addiction Product Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, and Nicotine Sublingual Tablets. The Drug Therapy is further studied across Chantix (Varenicline) and Zyban (Bupropion). The Nicotine Replacement Therapies is further studied across Nicotine Gums, Nicotine Lozenges, Nicotine Sprays, and Nicotine Transdermal Patches.
  • Based on Distribution, market is studied across Drug Store, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Prevalence of Numerous Diseases due to Smoking Such as Respiratory Disorders and Lung Cancer
      • 5.1.1.2. Expanding Market Penetration of De-Addiction Products Globally
      • 5.1.1.3. Favorable Government Initiatives to Promote Anti-Smoking Policy and Raising Awareness of the Health Impact due to Smoking
    • 5.1.2. Restraints
      • 5.1.2.1. Product Recalls by the Manufacturer and Companies owing to increasing Technical Faults and Stringent Approval Process
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing Approvals and Development of New Nicotine Replacement Products
      • 5.1.3.2. Significant Online Market Presence Coupled with Social and Communal Support for Smoking Cessation Products
    • 5.1.4. Challenges
      • 5.1.4.1. Side Effects Associated with the Continued Usage of De-Addiction Products Coupled with Rising of Alternatives to Tobacco
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rising adoption of E-cigarettes for smoking cessation
    • 5.2.2. Distribution: Customer inclination towards online pharmacies for convenience and discretion
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Smoking Cessation & Nicotine De-Addiction Product Market, by Product

  • 6.1. Introduction
  • 6.2. Drug Therapy
    • 6.2.1. Chantix (Varenicline)
    • 6.2.2. Zyban (Bupropion)
  • 6.3. E-Cigarettes
  • 6.4. Nicotine Inhalers
  • 6.5. Nicotine Replacement Therapies
    • 6.5.1. Nicotine Gums
    • 6.5.2. Nicotine Lozenges
    • 6.5.3. Nicotine Sprays
    • 6.5.4. Nicotine Transdermal Patches
  • 6.6. Nicotine Sublingual Tablets

7. Smoking Cessation & Nicotine De-Addiction Product Market, by Distribution

  • 7.1. Introduction
  • 7.2. Drug Store
  • 7.3. Hospital Pharmacies
  • 7.4. Online Pharmacies
  • 7.5. Retail Pharmacies

8. Americas Smoking Cessation & Nicotine De-Addiction Product Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Smoking Cessation & Nicotine De-Addiction Product Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Smoking Cessation & Nicotine De-Addiction Product Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. BC Cancer Launches Nicotine Replacement Therapy Pilot Program in Prince George
    • 11.3.2. Imperial Tobacco Canada Is Excited To Launch A Smoking Cessation Product
    • 11.3.3. NCDHHS Launches New QuitlineNC Services to Make Stopping Tobacco Use and Vaping More Accessible

Companies Mentioned

  • 1. 22nd Century Group, Inc.
  • 2. Alkalon A/S
  • 3. Axsome Therapeutics, Inc.
  • 4. British American Tobacco PLC
  • 5. Cipla Ltd.
  • 6. Ditch Labs
  • 7. Dr. Reddy's Laboratories Limited
  • 8. Enorama Pharma AB
  • 9. GlaxoSmithKline PLC
  • 10. Glenmark Pharmaceuticals Limited
  • 11. Imperial Tobacco Company of India Limited
  • 12. Itaconix
  • 13. Japan Tobacco Inc.
  • 14. Johnson & Johnson
  • 15. JUUL Labs, Inc.
  • 16. Novartis International AG
  • 17. Perrigo Company PLC
  • 18. Pfizer Inc.
  • 19. Philip Morris International Inc.
  • 20. Pierre Fabre S.A.
  • 21. Rusan Pharma Ltd.
  • 22. Samyang Holdings Corporation
  • 23. Sparsha Pharma International Pvt. Ltd.
  • 24. Strides Pharma Science Limited

LIST OF FIGURES

  • FIGURE 1. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET RESEARCH PROCESS
  • FIGURE 2. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET DYNAMICS
  • TABLE 7. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY CHANTIX (VARENICLINE), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ZYBAN (BUPROPION), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY E-CIGARETTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE GUMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE LOZENGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SPRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE SUBLINGUAL TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG STORE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY NICOTINE REPLACEMENT THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 194. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. SMOKING CESSATION & NICOTINE DE-ADDICTION PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023